Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Envoy Medical (COCH) EBT (2022 - 2025)

Envoy Medical's EBT history spans 4 years, with the latest figure at -$6.4 million for Q4 2025.

  • Quarterly results put EBT at -$6.4 million for Q4 2025, down 29.43% from a year ago — trailing twelve months through Dec 2025 was -$23.9 million (down 18.87% YoY), and the annual figure for FY2025 was -$23.9 million, down 18.87%.
  • EBT for Q4 2025 was -$6.4 million at Envoy Medical, down from -$6.2 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $12.5 million in Q1 2022 to a low of -$6.7 million in Q4 2023.
  • The 4-year median for EBT is -$4.9 million (2024), against an average of -$2.0 million.
  • The sharpest move saw EBT crashed 484.97% in 2023, then rose 26.63% in 2024.
  • Year by year, EBT stood at -$1.1 million in 2022, then crashed by 484.97% to -$6.7 million in 2023, then increased by 26.63% to -$4.9 million in 2024, then decreased by 29.43% to -$6.4 million in 2025.
  • According to Business Quant data, EBT over the past three periods came in at -$6.4 million, -$6.2 million, and -$5.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.